US20050256192A1 - Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual - Google Patents
Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual Download PDFInfo
- Publication number
- US20050256192A1 US20050256192A1 US11/119,168 US11916805A US2005256192A1 US 20050256192 A1 US20050256192 A1 US 20050256192A1 US 11916805 A US11916805 A US 11916805A US 2005256192 A1 US2005256192 A1 US 2005256192A1
- Authority
- US
- United States
- Prior art keywords
- arginine
- nutritional composition
- strength
- serving
- creatine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 115
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 104
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title claims abstract description 89
- 210000003205 muscle Anatomy 0.000 title claims abstract description 78
- 230000001965 increasing effect Effects 0.000 title claims abstract description 76
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 39
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 38
- 238000011084 recovery Methods 0.000 title claims abstract description 37
- 230000000694 effects Effects 0.000 title claims abstract description 36
- 230000001737 promoting effect Effects 0.000 title claims abstract description 36
- 230000007103 stamina Effects 0.000 title claims abstract description 36
- 230000004865 vascular response Effects 0.000 title claims abstract description 36
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 claims abstract description 85
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 claims abstract description 52
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims abstract description 51
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims abstract description 49
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims abstract description 48
- 229960003624 creatine Drugs 0.000 claims abstract description 48
- 239000006046 creatine Substances 0.000 claims abstract description 47
- 229930064664 L-arginine Natural products 0.000 claims abstract description 46
- 235000014852 L-arginine Nutrition 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 41
- 239000000284 extract Substances 0.000 claims abstract description 28
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims abstract description 26
- 229960002173 citrulline Drugs 0.000 claims abstract description 25
- 239000004395 L-leucine Substances 0.000 claims abstract description 24
- 235000019454 L-leucine Nutrition 0.000 claims abstract description 24
- 229960003136 leucine Drugs 0.000 claims abstract description 24
- 229960005261 aspartic acid Drugs 0.000 claims abstract description 23
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims abstract description 22
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims abstract description 22
- 229960004295 valine Drugs 0.000 claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 claims abstract description 21
- 241001236212 Pinus pinaster Species 0.000 claims abstract description 19
- 235000005105 Pinus pinaster Nutrition 0.000 claims abstract description 19
- 229940107131 ginseng root Drugs 0.000 claims abstract description 9
- 239000007894 caplet Substances 0.000 claims description 42
- PGRNZHOQVAPMFX-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;2-oxopentanedioic acid Chemical compound OC(=O)CCC(=O)C(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N PGRNZHOQVAPMFX-WCCKRBBISA-N 0.000 claims description 27
- KWTQSFXGGICVPE-WCCKRBBISA-N Arginine hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CCCN=C(N)N KWTQSFXGGICVPE-WCCKRBBISA-N 0.000 claims description 18
- ODKSFYDXXFIFQN-UHFFFAOYSA-N Arginine Chemical compound OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 15
- 229940049920 malate Drugs 0.000 claims description 12
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000011166 aliquoting Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims 2
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000017531 blood circulation Effects 0.000 description 63
- 239000013589 supplement Substances 0.000 description 28
- 240000004371 Panax ginseng Species 0.000 description 23
- 235000008434 ginseng Nutrition 0.000 description 23
- 235000002789 Panax ginseng Nutrition 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 17
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 14
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 14
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 13
- -1 e.g. Chemical compound 0.000 description 13
- 230000037406 food intake Effects 0.000 description 13
- 239000001856 Ethyl cellulose Substances 0.000 description 11
- 235000003140 Panax quinquefolius Nutrition 0.000 description 11
- 229920001249 ethyl cellulose Polymers 0.000 description 11
- 235000019325 ethyl cellulose Nutrition 0.000 description 11
- 239000011521 glass Substances 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 9
- 239000008121 dextrose Substances 0.000 description 9
- MEJYXFHCRXAUIL-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;hydrate Chemical compound O.NC(=N)N(C)CC(O)=O MEJYXFHCRXAUIL-UHFFFAOYSA-N 0.000 description 8
- 239000004475 Arginine Substances 0.000 description 8
- 235000009697 arginine Nutrition 0.000 description 8
- 229960003121 arginine Drugs 0.000 description 8
- 229960004826 creatine monohydrate Drugs 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 7
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 7
- 235000021355 Stearic acid Nutrition 0.000 description 7
- 239000001506 calcium phosphate Substances 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 7
- 229940038472 dicalcium phosphate Drugs 0.000 description 7
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 235000019359 magnesium stearate Nutrition 0.000 description 7
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 7
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 7
- 239000001103 potassium chloride Substances 0.000 description 7
- 235000011164 potassium chloride Nutrition 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 239000008117 stearic acid Substances 0.000 description 7
- 240000005373 Panax quinquefolius Species 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 150000001408 amides Chemical class 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 235000015872 dietary supplement Nutrition 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 235000012041 food component Nutrition 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 238000000576 coating method Methods 0.000 description 5
- 230000036449 good health Effects 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 229940106587 pine bark extract Drugs 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000004372 Polyvinyl alcohol Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 229920002770 condensed tannin Polymers 0.000 description 4
- 229930182494 ginsenoside Natural products 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920002451 polyvinyl alcohol Polymers 0.000 description 4
- 239000000454 talc Substances 0.000 description 4
- 229910052623 talc Inorganic materials 0.000 description 4
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000036470 plasma concentration Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 2
- CXQWRCVTCMQVQX-LSDHHAIUSA-N (+)-taxifolin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC=C(O)C(O)=C1 CXQWRCVTCMQVQX-LSDHHAIUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 2
- 0 *C(**I[C@@](CN)O)=O Chemical compound *C(**I[C@@](CN)O)=O 0.000 description 2
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 229920003096 Methocel™ K100M Polymers 0.000 description 2
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000021152 breakfast Nutrition 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 2
- 235000012734 epicatechin Nutrition 0.000 description 2
- BPMFZUMJYQTVII-UHFFFAOYSA-N guanidinoacetic acid Chemical compound NC(=N)NCC(O)=O BPMFZUMJYQTVII-UHFFFAOYSA-N 0.000 description 2
- 229920003130 hypromellose 2208 Polymers 0.000 description 2
- 229940031707 hypromellose 2208 Drugs 0.000 description 2
- 229940114920 maritime pine extract Drugs 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 235000020741 pine bark extract Nutrition 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- MBBREGJRSROLGD-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound NC(=N)N(C)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O MBBREGJRSROLGD-UHFFFAOYSA-N 0.000 description 1
- DLNGCCQFGNSBOP-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.NC(=N)N(C)CC(O)=O DLNGCCQFGNSBOP-UHFFFAOYSA-N 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 150000008544 L-leucines Chemical class 0.000 description 1
- 150000008554 L-valines Chemical class 0.000 description 1
- DNLCCKLBRUAMHI-DKWTVANSSA-N N=C(N)NC[C@H](N)C(=O)O.S Chemical compound N=C(N)NC[C@H](N)C(=O)O.S DNLCCKLBRUAMHI-DKWTVANSSA-N 0.000 description 1
- FTQFEKGSIYYVQC-DKWTVANSSA-N NC(=O)NC[C@H](N)C(=O)O.S Chemical compound NC(=O)NC[C@H](N)C(=O)O.S FTQFEKGSIYYVQC-DKWTVANSSA-N 0.000 description 1
- KBYKAGXJLSGKDW-DKWTVANSSA-N N[C@@H](CC(=O)O)C(=O)O.S Chemical compound N[C@@H](CC(=O)O)C(=O)O.S KBYKAGXJLSGKDW-DKWTVANSSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- 241000219095 Vitis Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 244000070384 Vitis labrusca Species 0.000 description 1
- 235000004282 Vitis labrusca Nutrition 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 229940093797 bioflavonoids Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- KQNGHARGJDXHKF-UHFFFAOYSA-N dihydrotamarixetin Natural products C1=C(O)C(OC)=CC=C1C1C(O)C(=O)C2=C(O)C=C(O)C=C2O1 KQNGHARGJDXHKF-UHFFFAOYSA-N 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- SFCXZJXAXDZIGW-UHFFFAOYSA-L magnesium 2-[carbamimidoyl(methyl)amino]acetate Chemical compound [Mg+2].NC(=N)N(C)CC([O-])=O.NC(=N)N(C)CC([O-])=O SFCXZJXAXDZIGW-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NAJVRARAUNYNDX-UHFFFAOYSA-N picamilon Chemical compound OC(=O)CCCNC(=O)C1=CC=CN=C1 NAJVRARAUNYNDX-UHFFFAOYSA-N 0.000 description 1
- 235000018192 pine bark supplement Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 229940106796 pycnogenol Drugs 0.000 description 1
- 230000004648 relaxation of smooth muscle Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000010215 titanium dioxide Nutrition 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Definitions
- the present invention relates to a novel nutritional composition which provides for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, a method for achieving same by consuming the nutritional composition and to a method of manufacturing the nutritional composition.
- the present invention in accordance with one embodiment thereof, provides for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, e.g., a human or animal.
- the nutritional composition includes ______.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing a nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a timed release delivery system for a novel nutritional composition, the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- an effective amount refers to an amount effective for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual when administered over a period of week(s) in accordance with a predetermined dosage regimen, e.g., in accordance with the dosage charts set forth in greater detail below.
- An effective amount of the nutritional composition is preferably from about 0.1 g to about 20 g of the nutritional composition per serving. More preferably, an effective amount of the composition comprises from about 1 g to about 10 g of the nutritional composition per serving. Most preferably, an effective amount of the composition comprises about 7.5 g of the nutritional composition. In another preferred embodiment of the invention, an effective amount of the composition most preferably comprises about 5.85 g of the nutritional composition.
- essentially pure preferably refers to a compound that is greater than about 90% pure. More preferably, “essentially pure” refers to a compound that is greater than about 95% pure. Most preferably, “essentially pure” refers to a compound that is greater than about 98% pure.
- enriched refers to a partially purified extract or composition from which undesirable impurities have been removed.
- the undesirable impurities may be a single compound or multiple compounds.
- enriched refers to a composition in which at least 25% of the undesirable impurities have been removed. More preferably, “enriched” refers to a composition in which at least 50% of the undesirable impurities have been removed. Most preferably, “enriched” refers to a composition in which at least 75% of the undesirable impurities have been removed.
- muscle pump refers to the flow of blood through the veins when muscular contraction compresses the blood veins, which increases the pressure within the veins and exerts pressure on the blood, causing it to flow, thereby acting as a pumping mechanism.
- One embodiment of the invention provides for a nutritional composition including L-arginine, e.g., L-arginine HCL and/or L-arginine alphaketoglutarate, creatine, L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract.
- L-arginine e.g., L-arginine HCL and/or L-arginine alphaketoglutarate
- creatine e.g., L-arginine HCL and/or L-arginine alphaketoglutarate
- creatine e.g., L-citrulline, L-aspartic acid
- ginseng root extract ginseng root extract
- maritime pine (bark) extract maritime pine
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- the present invention in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- This embodiment of the present invention may employ a 5 caplet serving.
- this embodiment is provided in the dosage form of a drink which may be stored as a powder and reconstituted into a drink at the time of ingestion.
- the nutritional composition is for use by men.
- a nutritional composition including about 3.1 g of L-arginine, e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine malate, about 0.1 g of L-citrulline, about 0.1 g of L-aspartic acid, about 0.05 g of ginseng root extract, and about 2 mg of maritime pine (bark) extract per serving.
- L-arginine e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate
- about 1.5 g of creatine malate about 0.1 g of L-citrulline, about 0.1 g of L-aspartic acid, about 0.05 g of ginseng root extract, and about 2 mg of maritime pine (bark) extract per serving.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine, di-creatine malate, L-arginine alphaketoglutarate, picamilone HCL, asian ginseng powder root extract ( Panax ginseng )L-Citrulline, L-aspartic acid and French maritime pine bark extract.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- this embodiment is provided in the dosage form of a drink which may be stored as a powder and reconstituted into a drink at the time of ingestion.
- Examples 7 and 9 set forth below illustrate two examples of such embodiments of the present invention.
- this embodiment is provided in the dosage form of a caplet.
- Example 11 set forth below illustrates an example of this embodiment of the present invention.
- a nutritional composition including about 4.0 g L-arginine, about 1.5 g of di-creatine malate, about 0.1 g of L-arginine alpha ketaglutarate, about 0.1 g of picamilone HCL, about 0.05 g of asian ginseng powder root extract ( Panax ginseng ), about 0.5 g of L-Citrulline, about 0.05 g of L-aspartic acid and about 0.002 g of French maritime pine bark extract per serving.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine, e.g., L-arginine HCL and/or L-arginine alphaketoglutarate, creatine hydrates (including but not limited to creatine monohydrate), L-leucine and L-valine.
- L-arginine e.g., L-arginine HCL and/or L-arginine alphaketoglutarate
- creatine hydrates including but not limited to creatine monohydrate
- L-leucine and L-valine L-valine
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- the present invention in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- this embodiment of the present invention employs a 5 caplet serving.
- a nutritional composition including about 3.0 g of L-arginine, e.g., about 2.9 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine monohydrate, about 0.1 g of L-valine, and about 0.1 g of L-leucine.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine HCL and L-arginine alpha ketoglutarate, creatine hydrates (including but not limited to creatine monohydrate), L-leucine and L-valine.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- the present invention in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- this embodiment of the present invention employs a 3 caplet serving.
- a nutritional composition including about 1.74 g of L-arginine HCL and 0.06 g of L-arginine alpha ketoglutarate, about 0.9 g of creatine monohydrate, about 0.06 g of L-valine, and about 0.06 g of L-leucine.
- the present invention in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the present invention in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- the present invention in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- the nutritional composition of the invention increases blood flow to skeletal muscle by exploiting the mechanisms involved in nitric oxide (NO) production and smooth muscle relaxation. It is believed that the nutritional composition of the invention increases the dilation of blood vessels, which increases the delivery of nutrients and oxygen while assisting the removal of waste byproducts of metabolism. Increasing NO production by consumption of the nutritional composition of the invention results in wider blood vessels, which can carry more blood to muscles. The increased flow of blood results in delivery of nutrients, oxygen and hormones needed for growth and repair and helps remove undesirable byproducts of metabolism that fatigue muscles.
- NO nitric oxide
- L-arginine also referred to as (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid, (CAS Registry No. 74-79-3), is a naturally occurring amino acid.
- L-arginine also includes derivatives of L-arginine such as esters, and amides, and salts, as well as other derivatives, including derivatives that become active upon metabolism.
- the structure of L-arginine is as follows:
- L-arginine is a substrate for NO synthetase and that the ingestion of L-arginine by an animal increases the plasma concentration of L-arginine. It is further believed that increased plasma concentration of L-arginine enhances nitric oxide production by enhancing the concentration of the NO synthetase substrate L-arginine.
- the nutritional composition of the invention preferably comprises a salt of L-arginine selected from the group consisting of L-arginine hydrochloride and L-arginine alpha-ketoglutarate. More preferably, the nutritional composition of the invention comprises a combination of salts of L-arginine salts comprising L-arginine hydrochloride and L-arginine alpha-ketoglutarate.
- the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of at least about 10 to 1. More preferably, the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of at least about 20 to 1. Most preferably, the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of about 30 to 1.
- a serving of the nutritional substrate comprises from about 1 g to about 30 g of an L-arginine salt per serving. More preferably, a serving of the nutritional substrate comprises from about 5 g to about 10 g of an L-arginine salt per serving. In one embodiment, a serving of the nutritional substrate comprises about 3.0 g to about 3.1 g of an L-arginine salt per serving. In another embodiment, a serving of the nutritional substrate comprises about 1.70 to 1.80 g of an L-arginine salt per serving.
- the nutritional composition of the invention preferably comprises L-arginine base instead of or in addition to a L-arginine salt.
- this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of at least about 10 to 1. More preferably, this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of at least about 20 to 1. Most preferably, this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of about 40 to 1.
- a serving of this nutritional substrate comprises from about 1 g to about 30 g of a L-arginine base per serving. More preferably, a serving of this nutritional substrate comprises from about 5 g to about 10 g of an L-arginine base per serving. In one embodiment, a serving of the nutritional substrate comprises about 4.0 g of an L-arginine base per serving.
- creatine refers to the chemical compound N-methyl-N-guanyl glycine, (CAS Registry No. 57-00-1), also known as, (a-methyl guanido)acetic acid, N-(aminoiminomethyl)-N-glycine, and methylglycocyamine, and Methylguanidoacetic acid, and N-Methyl-N-guanylglycine, whose chemical structure is shown below.
- Creatine also includes derivatives of creatine such as esters, and amides, and salts, as well as other derivatives, including derivatives that become active upon metabolism.
- the chemical structure of creatine is as follows:
- creatine increases strength and muscle size as well as cell volumization.
- Creatine and creatine derivatives are widely available from a number of commercial sources.
- Commercially available creatine derivatives include creatine phosphate, creatine citrate, magnesium creatine, alkaline creatine, creatine pyruvate, creatine hydrates (including, but not limited to creatine monohydrate), and creatine malate.
- Glycocyamine an in vivo precursor of creatine, is also commercially available and suitable in the practice of the present invention.
- the supplement preferably comprises creatine malate or creatine monohydrate.
- a serving of the supplement comprises from about 0.1 g to about 10 g of creatine. More preferably, a serving of the supplement comprises from about 0.5 g to about 5 g of creatine. In one embodiment, a serving of the supplement comprises about 1.5 g of creatine. In another embodiment, a serving of the supplement comprises about 0.9 g of creatine.
- L-citrulline is a naturally occurring amino acid, also known as L-N5-(aminocarbonyl)-Ornithine (CAS Registry No. 372-75-8). As used herein, “L-citrulline” also includes derivatives of L-citrulline such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-citrulline is as follows:
- L-citrulline is a metabolic precursor to L-arginine.
- L-citrulline increases de novo arginine synthesis thereby increasing the arginine pool. It is hypothesized that ingestion of L-citrulline indirectly supports nitric oxide production by enhancing the plasma concentration of L-arginine substrate for NO synthetase.
- a serving of the supplement comprises from about 0.01 g to about 10 g of L-citrulline. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-citrulline. Most preferably, a serving of the supplement comprises about 0.1 g of L-citrulline.
- L-leucine is a naturally occurring amino acid, also known as (S)-2-amino-4-methylpentanoic acid (CAS Registry No. 61-90-5). As used herein, “L-leucine” also includes derivatives of L-leucine such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-leucine is as follows:
- a serving of the supplement in one embodiment comprises from about 0.01 g to about 10 g of L-leucine. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-leucine. In one embodiment, a serving of the supplement comprises about 0.1 g of L-leucine. In another embodiment, a serving of the supplement comprises about 0.06 g of L-leucine.
- L-aspartic acid is a naturally occurring amino acid, also known as (S)-Aminobutanedioic acid (CAS Registry No. 56-84-8). As used herein, “L-aspartic acid” also includes derivatives of L-aspartic acid such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-aspartic acid is as follows:
- a serving of the supplement comprises from about 0.01 g to about 10 g of L-aspartic acid per serving. More preferably, a serving of the supplement comprises from about 0.02 g to about 2 g of L-aspartic acid per serving. Most preferably, a serving of the supplement comprises about 0.05 g of L-aspartic acid per serving.
- L-valine is a naturally occurring amino acid, also known as (S)-2-amino-3-methylbutanoic acid (CAS Registry No. 72-18-4). As used herein, “L-valine” also includes derivatives of L-valine such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism.
- the chemical structure of L-valine is as follows:
- a serving of the supplement in one embodiment comprises from about 0.01 g to about 10 g of L-valine. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-valine. In one embodiment, a serving of the supplement comprises about 0.1 g of L-valine. In another embodiment, a serving of the supplement comprises about 0.06 g of L-valine.
- Ginseng preferably refers to American ginseng ( Panax quinquefolium L.), or Korean Ginseng ( Panax Ginseng ) or Siberian Ginseng (( Eleutherococcus senticosus ) and derivatives thereof. Most preferably Ginseng refers to American Ginseng ( Panax quinquefolium L.), or Korean Ginseng ( Panax Ginseng ) and derivatives thereof.
- Ginseng stimulates the production of nitric oxide.
- a serving of the supplement preferably comprises from about 0.001 g to about 0.5 g of American Ginseng or Korean Ginseng per serving. More preferably, a serving of the supplement comprises from about 0.01 g to about 0.1 g of American Ginseng or Korean Ginseng per serving. Most preferably, a serving of the supplement comprises about 0.01 g of Korean Ginseng ( Panax Ginseng ) per serving.
- French Maritime Pine extract preferably refers to an aqueous extract of the bark of the French maritime pine grown as a mono-species forest, spread over the coastal region of south-west France and preferably comprises a natural blend of genetically programmed constant proportions of bioflavonoids including catechin, epicatechin, taxifolin, monomers, dimers of catechin and epicatechin, oligomeric procyanidnins and phenolic fruit acids such as ferulic acid and caffeic acid. See U.S. Pat. No. 4,698,360, incorporated herein by reference in its entirety.
- a serving of the supplement comprises from about 0.01 mg to about 20 mg of French maritime pine tree bark extract per serving. More preferably, a serving of the supplement comprises from about 0.1 mg to about 10 mg of French maritime pine tree bark extract per serving. Most preferably, a serving of the supplement comprises about 2 mg of French maritime pine tree bark extract per serving.
- the nutritional composition may contain a variety of excipients.
- the present invention in one embodiment, provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition that includes L-arginine, creatine, L-aspartic acid, L-citrulline, ginseng root extract and maritime pine (bark) extract.
- a nutritional composition that includes L-arginine, creatine, L-aspartic acid, L-citrulline, ginseng root extract and maritime pine (bark) extract.
- the present invention in one embodiment, provides for a nutritional composition including about 3.1 g of L-arginine, e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine, about 0.1 g of L-aspartic acid, about 0.1 g of L-citrulline, 0.05 g of ginseng root extract and about 2 mg of maritime pine (bark) extract per serving.
- L-arginine e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate
- about 1.5 g of creatine about 0.1 g of L-aspartic acid, about 0.1 g of L-citrulline, 0.05 g of ginseng root extract and about 2 mg of maritime pine (bark) extract per serving.
- the method also includes a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the nutritional composition is consumed in accordance with the following directions and dosing chart: DIRECTIONS: Based upon a person's bodyweight, take one serving (3 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period.
- the present invention provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition comprising L-arginine, creatine, L-leucine, L-valine.
- the present invention provides for a nutritional composition including about 3.0 g of L-arginine, e.g., about 2.9 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine, about 0.1 g of L-leucine and about 0.1 g of L-valine.
- the method further comprises a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the nutritional composition is consumed in accordance with the following directions and dosing chart: DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second Gender/lbs First serving Serving First serving Serving Women ⁇ 125 2 2 3 3 Women > 125 3 3 4 4 Men ⁇ 200 3 3 4 4 Men > 200 4 4 5 5
- the present invention provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition comprising L-arginine, creatine, L-leucine, L-valine.
- the present invention provides for a nutritional composition including about 1.74 g of L-arginine HCL, 0.060 g of L-arginine alpha ketoglutarate, about 0.9 g of creatine, about 0.06 g of L-leucine and about 0.06 g of L-valine.
- the method further comprises a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- the nutritional composition is consumed in accordance with the following directions and dosing chart: DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second Gender/lbs First serving Serving First serving Serving Women ⁇ 125 2 2 3 3 Women > 125 3 3 4 4 Men ⁇ 200 3 3 4 4 Men > 200 4 4 5 5
- the present invention also provides for a method of making a nutritional composition that includes the steps of mixing the following ingredients: L-arginine HCL, L-arginine alphaketoglutarate, creatine, L-aspartic acid, L-citrulline, ginseng root extract and maritime pine (bark) extract; and in an additional step, adding the following excipients: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, dicalcium phosphate, polyvinyl alcohol, polyethylene glycol, FD&C Red No. 40, talc, and titanium dioxide.
- the method also includes the step of blending and mixing for 30 minutes.
- the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- the present invention provides for a method of making a nutritional composition including the steps of mixing the following ingredients: L-arginine HCL, L-arginine alphaketoglutarate, creatine, L-leucine and L-valine; and in an additional step, adding the following excipient: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, dicalcium phosphate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, and talc.
- the method also includes the step of blending and mixing for 30 minutes.
- the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- the present invention provides for a method of making a nutritional composition including the steps of mixing the following ingredients: L-arginine HCL and L-arginine alpha ketoglutarate, creatine, L-leucine and L-valine; and in an additional step, adding the following excipient: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, FD&C Red No. 40, polyvinyl alcohol, polyethylene glycol, talc, and dicalcium phosphate which had been pre-sifted.
- the method also includes the step of blending and mixing for 30 minutes.
- the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- the present invention may also provide for a timed release delivery system for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, which includes a combination of pharmaceutical grade excipients including Hydroxypropyl Methyl Cellulose (Methocel K100M Premium CR EP-Hypromellose 2208 USP XXII), Ethyl Cellulose (Ethocel Standard FP Premium—NF XVII), and Hydroxypropylcellulose (Klucel LF—NF XVII).
- a timed release delivery system for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for n
- the present invention may also provide for a timed release delivery system for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, which comprises a hydrophilic caplet matrix system comprising water-soluble (i.e., Hydroxypropyl Methyl Cellulose and Hydroxypropylcellulose) and water-insoluble (i.e., Ethyl Cellulose) polymers uniformly incorporated at a specified ratio.
- a hydrophilic caplet matrix system comprising water-soluble (i.e., Hydroxypropyl Methyl Cellulose and Hydroxypropylcellulose) and water-insoluble (i.e., Ethyl Cellulose) polymers uniformly incorporated at a specified ratio.
- the novel nutritional composition includes a hydrophilic caplet matrix system which is in the ratio of 1 Hydroxypropylcellulose:1 Ethyl Cellulose:0.5 Hydroxypropyl Methyl Cellulose.
- a serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
- the caplet form may contain a coating such as Opadry II.
- a serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in accordance with the following directions and dosing chart:
- An alternate embodiment of the serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
- the caplet form may contain a coating such as Opadry II.
- An alternate embodiment of the serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in accordance with the following directions and dosing chart: DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz.
- the average (n 6) % of labeled amount of arginine dissolved from one caplet of the nutritional supplement for inducing muscle pump and enhancing muscle stimulus and recovery in 900 ml of 0.1N Hydrochloric Acid: Average % of Labeled Amount of Arginine Average Mg of Arginine Time (Minutes) Dissolved ⁇ Std. Dev. Dissolved ⁇ Std. Dev.
- a serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
- a serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in powder form reconstituted into a drink.
- Actives % serving (g) Formula % L-arginine 4.0000 68.3527% Di-Creatine Malate 1.5000 25.6323% Creatine 63 0.9450 L-arginine alpha ketaglutarate (2:1) 0.1000 1.7088% Arginine 69 0.0690 Picamilone HCL 0.1000 1.7088% Asian Ginseng Powder root extract 0.0500 0.8544% (Panax ginseng) Ginsenosides (standardized) 25 0.0125 L-Citrulline 0.0500 0.8544% L-aspartic acid 0.0500 0.8544% French Maritime Pine Bark Extract 0.0020 0.0342% Proanthocyanidins Standardized (Pinus 70 0.0014 Maritima) 5.8520 100.00% Other Ingredients g/serving % Dextrose 6.0000 62.9% Citric Acid 2.4600 25.8% SD N&A Bitter Blocker 0.6250 6.5% SD N&A Concord Grape Fla
- Example 7 One serving of the supplement of Example 7 is consumed by a human, twice daily.
- a serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in powder form reconstituted into a drink.
- Example 9 One serving of the supplement of Example 9 is consumed by a human, twice daily.
- a serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in caplet form.
- Example 11 One serving of the supplement of Example 11 is consumed by a human, twice daily, each serving including 5 caplets.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
A nutritional composition, the consumption of which provides a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in individuals. The nutritional composition may include L-arginine and creatine. In addition, the nutritional composition may also include L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract. Alternatively, the nutritional composition may also include L-leucine and L-valine. A method of manufacturing the nutritional composition is also provided.
Description
- This application is related to U.S. Provisional Patent Application Ser. No. 60/658,782, filed on Mar. 3, 2005, U.S. Provisional Patent Application Ser. No. 60/613,441, filed on Sep. 24, 2004, and U.S. Provisional Patent Application Ser. No. 60/567,127, filed on Apr. 30, 2004, each of which is hereby incorporated by reference in its entirety.
- The present invention relates to a novel nutritional composition which provides for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, a method for achieving same by consuming the nutritional composition and to a method of manufacturing the nutritional composition.
- The present invention, in accordance with one embodiment thereof, provides for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, e.g., a human or animal. In one embodiment, the nutritional composition includes ______.
- The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing a nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- Still further, the present invention, in accordance with one embodiment thereof, provides a timed release delivery system for a novel nutritional composition, the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual.
- As used herein, “an effective amount” refers to an amount effective for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual when administered over a period of week(s) in accordance with a predetermined dosage regimen, e.g., in accordance with the dosage charts set forth in greater detail below. An effective amount of the nutritional composition is preferably from about 0.1 g to about 20 g of the nutritional composition per serving. More preferably, an effective amount of the composition comprises from about 1 g to about 10 g of the nutritional composition per serving. Most preferably, an effective amount of the composition comprises about 7.5 g of the nutritional composition. In another preferred embodiment of the invention, an effective amount of the composition most preferably comprises about 5.85 g of the nutritional composition.
- As used herein, “essentially pure” preferably refers to a compound that is greater than about 90% pure. More preferably, “essentially pure” refers to a compound that is greater than about 95% pure. Most preferably, “essentially pure” refers to a compound that is greater than about 98% pure.
- As used herein, “enriched” refers to a partially purified extract or composition from which undesirable impurities have been removed. The undesirable impurities may be a single compound or multiple compounds. Preferably, “enriched” refers to a composition in which at least 25% of the undesirable impurities have been removed. More preferably, “enriched” refers to a composition in which at least 50% of the undesirable impurities have been removed. Most preferably, “enriched” refers to a composition in which at least 75% of the undesirable impurities have been removed.
- As used herein, “muscle pump” refers to the flow of blood through the veins when muscular contraction compresses the blood veins, which increases the pressure within the veins and exerts pressure on the blood, causing it to flow, thereby acting as a pumping mechanism.
- One embodiment of the invention provides for a nutritional composition including L-arginine, e.g., L-arginine HCL and/or L-arginine alphaketoglutarate, creatine, L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition. This embodiment of the present invention may employ a 5 caplet serving. Preferably, this embodiment is provided in the dosage form of a drink which may be stored as a powder and reconstituted into a drink at the time of ingestion. In one embodiment, the nutritional composition is for use by men.
- For instance, in one such embodiment of the invention there is provided for a nutritional composition including about 3.1 g of L-arginine, e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine malate, about 0.1 g of L-citrulline, about 0.1 g of L-aspartic acid, about 0.05 g of ginseng root extract, and about 2 mg of maritime pine (bark) extract per serving. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine, di-creatine malate, L-arginine alphaketoglutarate, picamilone HCL, asian ginseng powder root extract (Panax ginseng)L-Citrulline, L-aspartic acid and French maritime pine bark extract. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. Preferably, this embodiment is provided in the dosage form of a drink which may be stored as a powder and reconstituted into a drink at the time of ingestion. Examples 7 and 9 set forth below illustrate two examples of such embodiments of the present invention. Alternatively, this embodiment is provided in the dosage form of a caplet. Example 11 set forth below illustrates an example of this embodiment of the present invention.
- For instance, in one such embodiment of the invention there is provided for a nutritional composition including about 4.0 g L-arginine, about 1.5 g of di-creatine malate, about 0.1 g of L-arginine alpha ketaglutarate, about 0.1 g of picamilone HCL, about 0.05 g of asian ginseng powder root extract (Panax ginseng), about 0.5 g of L-Citrulline, about 0.05 g of L-aspartic acid and about 0.002 g of French maritime pine bark extract per serving. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine, e.g., L-arginine HCL and/or L-arginine alphaketoglutarate, creatine hydrates (including but not limited to creatine monohydrate), L-leucine and L-valine. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition. Advantageously, this embodiment of the present invention employs a 5 caplet serving.
- For instance, in one such embodiment of the invention there is provided for a nutritional composition including about 3.0 g of L-arginine, e.g., about 2.9 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine monohydrate, about 0.1 g of L-valine, and about 0.1 g of L-leucine. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- Another embodiment of the invention provides for a nutritional composition including L-arginine HCL and L-arginine alpha ketoglutarate, creatine hydrates (including but not limited to creatine monohydrate), L-leucine and L-valine. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition. Advantageously, this embodiment of the present invention employs a 3 caplet serving.
- For instance, in one such embodiment of the invention there is provided for a nutritional composition including about 1.74 g of L-arginine HCL and 0.06 g of L-arginine alpha ketoglutarate, about 0.9 g of creatine monohydrate, about 0.06 g of L-valine, and about 0.06 g of L-leucine. The present invention, in accordance with one embodiment thereof, also provides, by the ingestion of the novel nutritional composition, a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Furthermore, the present invention, in accordance with one embodiment thereof, provides a method of manufacturing such a nutritional composition. The present invention, in accordance with one embodiment thereof, provides a timed release delivery system for the novel nutritional composition.
- While not wishing to be bound by theory it is believed that the nutritional composition of the invention increases blood flow to skeletal muscle by exploiting the mechanisms involved in nitric oxide (NO) production and smooth muscle relaxation. It is believed that the nutritional composition of the invention increases the dilation of blood vessels, which increases the delivery of nutrients and oxygen while assisting the removal of waste byproducts of metabolism. Increasing NO production by consumption of the nutritional composition of the invention results in wider blood vessels, which can carry more blood to muscles. The increased flow of blood results in delivery of nutrients, oxygen and hormones needed for growth and repair and helps remove undesirable byproducts of metabolism that fatigue muscles.
- L-arginine
- L-arginine, also referred to as (S)-2-Amino-5-[(aminoiminomethyl)amino]pentanoic acid, (CAS Registry No. 74-79-3), is a naturally occurring amino acid. As used herein, “L-arginine” also includes derivatives of L-arginine such as esters, and amides, and salts, as well as other derivatives, including derivatives that become active upon metabolism. The structure of L-arginine is as follows:
- While not being bound by theory it is believed that L-arginine is a substrate for NO synthetase and that the ingestion of L-arginine by an animal increases the plasma concentration of L-arginine. It is further believed that increased plasma concentration of L-arginine enhances nitric oxide production by enhancing the concentration of the NO synthetase substrate L-arginine.
- The nutritional composition of the invention preferably comprises a salt of L-arginine selected from the group consisting of L-arginine hydrochloride and L-arginine alpha-ketoglutarate. More preferably, the nutritional composition of the invention comprises a combination of salts of L-arginine salts comprising L-arginine hydrochloride and L-arginine alpha-ketoglutarate.
- Preferably, the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of at least about 10 to 1. More preferably, the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of at least about 20 to 1. Most preferably, the nutritional composition of the invention comprises L-arginine hydrochloride and L-arginine alpha-ketoglutarate in a ratio of about 30 to 1.
- Preferably, a serving of the nutritional substrate comprises from about 1 g to about 30 g of an L-arginine salt per serving. More preferably, a serving of the nutritional substrate comprises from about 5 g to about 10 g of an L-arginine salt per serving. In one embodiment, a serving of the nutritional substrate comprises about 3.0 g to about 3.1 g of an L-arginine salt per serving. In another embodiment, a serving of the nutritional substrate comprises about 1.70 to 1.80 g of an L-arginine salt per serving.
- In another preferred embodiment, the nutritional composition of the invention preferably comprises L-arginine base instead of or in addition to a L-arginine salt. Preferably, this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of at least about 10 to 1. More preferably, this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of at least about 20 to 1. Most preferably, this nutritional composition of the invention comprises L-arginine and L-arginine alpha-ketoglutarate in a ratio of about 40 to 1.
- Preferably, a serving of this nutritional substrate comprises from about 1 g to about 30 g of a L-arginine base per serving. More preferably, a serving of this nutritional substrate comprises from about 5 g to about 10 g of an L-arginine base per serving. In one embodiment, a serving of the nutritional substrate comprises about 4.0 g of an L-arginine base per serving.
- Creatine
- As used herein, “creatine” refers to the chemical compound N-methyl-N-guanyl glycine, (CAS Registry No. 57-00-1), also known as, (a-methyl guanido)acetic acid, N-(aminoiminomethyl)-N-glycine, and methylglycocyamine, and Methylguanidoacetic acid, and N-Methyl-N-guanylglycine, whose chemical structure is shown below. As used herein, “creatine” also includes derivatives of creatine such as esters, and amides, and salts, as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of creatine is as follows:
- While not wishing to be bound by theory it is believed that creatine increases strength and muscle size as well as cell volumization.
- Creatine and creatine derivatives are widely available from a number of commercial sources. Commercially available creatine derivatives include creatine phosphate, creatine citrate, magnesium creatine, alkaline creatine, creatine pyruvate, creatine hydrates (including, but not limited to creatine monohydrate), and creatine malate. Glycocyamine, an in vivo precursor of creatine, is also commercially available and suitable in the practice of the present invention. The supplement preferably comprises creatine malate or creatine monohydrate.
- As used herein, a serving of the supplement comprises from about 0.1 g to about 10 g of creatine. More preferably, a serving of the supplement comprises from about 0.5 g to about 5 g of creatine. In one embodiment, a serving of the supplement comprises about 1.5 g of creatine. In another embodiment, a serving of the supplement comprises about 0.9 g of creatine.
- L-citrulline
- “L-citrulline” is a naturally occurring amino acid, also known as L-N5-(aminocarbonyl)-Ornithine (CAS Registry No. 372-75-8). As used herein, “L-citrulline” also includes derivatives of L-citrulline such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-citrulline is as follows:
- While not being bound by theory, it is believed that L-citrulline is a metabolic precursor to L-arginine. Thus, L-citrulline increases de novo arginine synthesis thereby increasing the arginine pool. It is hypothesized that ingestion of L-citrulline indirectly supports nitric oxide production by enhancing the plasma concentration of L-arginine substrate for NO synthetase.
- As used herein, a serving of the supplement comprises from about 0.01 g to about 10 g of L-citrulline. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-citrulline. Most preferably, a serving of the supplement comprises about 0.1 g of L-citrulline.
- L-leucine
- “L-leucine” is a naturally occurring amino acid, also known as (S)-2-amino-4-methylpentanoic acid (CAS Registry No. 61-90-5). As used herein, “L-leucine” also includes derivatives of L-leucine such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-leucine is as follows:
- As used herein, a serving of the supplement in one embodiment comprises from about 0.01 g to about 10 g of L-leucine. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-leucine. In one embodiment, a serving of the supplement comprises about 0.1 g of L-leucine. In another embodiment, a serving of the supplement comprises about 0.06 g of L-leucine.
- L-aspartic Acid
- “L-aspartic acid” is a naturally occurring amino acid, also known as (S)-Aminobutanedioic acid (CAS Registry No. 56-84-8). As used herein, “L-aspartic acid” also includes derivatives of L-aspartic acid such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-aspartic acid is as follows:
- While not being bound by theory it is believed that aspartic acid facilitates the production of nitric oxide.
- As used herein, a serving of the supplement comprises from about 0.01 g to about 10 g of L-aspartic acid per serving. More preferably, a serving of the supplement comprises from about 0.02 g to about 2 g of L-aspartic acid per serving. Most preferably, a serving of the supplement comprises about 0.05 g of L-aspartic acid per serving.
- L-valine
- “L-valine” is a naturally occurring amino acid, also known as (S)-2-amino-3-methylbutanoic acid (CAS Registry No. 72-18-4). As used herein, “L-valine” also includes derivatives of L-valine such as esters, amides, and salts as well as other derivatives, including derivatives that become active upon metabolism. The chemical structure of L-valine is as follows:
- As used herein, a serving of the supplement in one embodiment comprises from about 0.01 g to about 10 g of L-valine. More preferably, a serving of the supplement comprises from about 0.05 g to about 2 g of L-valine. In one embodiment, a serving of the supplement comprises about 0.1 g of L-valine. In another embodiment, a serving of the supplement comprises about 0.06 g of L-valine.
- Ginseng
- As used herein Ginseng preferably refers to American ginseng (Panax quinquefolium L.), or Korean Ginseng (Panax Ginseng) or Siberian Ginseng ((Eleutherococcus senticosus) and derivatives thereof. Most preferably Ginseng refers to American Ginseng (Panax quinquefolium L.), or Korean Ginseng (Panax Ginseng) and derivatives thereof.
- While not being bound by theory it is believed that Ginseng stimulates the production of nitric oxide.
- As used herein, a serving of the supplement preferably comprises from about 0.001 g to about 0.5 g of American Ginseng or Korean Ginseng per serving. More preferably, a serving of the supplement comprises from about 0.01 g to about 0.1 g of American Ginseng or Korean Ginseng per serving. Most preferably, a serving of the supplement comprises about 0.01 g of Korean Ginseng (Panax Ginseng) per serving.
- French Maritime Pine Extract
- French Maritime Pine extract preferably refers to an aqueous extract of the bark of the French maritime pine grown as a mono-species forest, spread over the coastal region of south-west France and preferably comprises a natural blend of genetically programmed constant proportions of bioflavonoids including catechin, epicatechin, taxifolin, monomers, dimers of catechin and epicatechin, oligomeric procyanidnins and phenolic fruit acids such as ferulic acid and caffeic acid. See U.S. Pat. No. 4,698,360, incorporated herein by reference in its entirety.
- While not being bound by theory it is believed that the extract from the bark of French maritime pine tree supports circulation by preventing constriction of arteries and blood clotting.
- As used herein, a serving of the supplement comprises from about 0.01 mg to about 20 mg of French maritime pine tree bark extract per serving. More preferably, a serving of the supplement comprises from about 0.1 mg to about 10 mg of French maritime pine tree bark extract per serving. Most preferably, a serving of the supplement comprises about 2 mg of French maritime pine tree bark extract per serving.
- Those of skill in the art will appreciate that the nutritional composition may contain a variety of excipients.
- As set forth above, the present invention, in one embodiment, provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition that includes L-arginine, creatine, L-aspartic acid, L-citrulline, ginseng root extract and maritime pine (bark) extract. For instance, the present invention, in one embodiment, provides for a nutritional composition including about 3.1 g of L-arginine, e.g., about 3.0 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine, about 0.1 g of L-aspartic acid, about 0.1 g of L-citrulline, 0.05 g of ginseng root extract and about 2 mg of maritime pine (bark) extract per serving. Advantageously, the method also includes a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Preferably, the nutritional composition is consumed in accordance with the following directions and dosing chart:
DIRECTIONS: Based upon a person's bodyweight, take one serving (3 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second First serving Serving First serving Serving Men < 200 lbs 3 3 4 4 Men > 200 lbs 4 4 5 5 - In an alternate embodiment, the present invention provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition comprising L-arginine, creatine, L-leucine, L-valine. For instance, in one embodiment, the present invention provides for a nutritional composition including about 3.0 g of L-arginine, e.g., about 2.9 g of L-arginine HCL and about 0.1 g of L-arginine alphaketoglutarate, about 1.5 g of creatine, about 0.1 g of L-leucine and about 0.1 g of L-valine. Advantageously, the method further comprises a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Preferably, the nutritional composition is consumed in accordance with the following directions and dosing chart:
DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second Gender/lbs First serving Serving First serving Serving Women < 125 2 2 3 3 Women > 125 3 3 4 4 Men < 200 3 3 4 4 Men > 200 4 4 5 5 - In an alternate embodiment, the present invention provides for a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, by consuming a nutritional composition comprising L-arginine, creatine, L-leucine, L-valine. For instance, in one embodiment, the present invention provides for a nutritional composition including about 1.74 g of L-arginine HCL, 0.060 g of L-arginine alpha ketoglutarate, about 0.9 g of creatine, about 0.06 g of L-leucine and about 0.06 g of L-valine. Advantageously, the method further comprises a workout to facilitate the process of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual. Preferably, the nutritional composition is consumed in accordance with the following directions and dosing chart:
DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second Gender/lbs First serving Serving First serving Serving Women < 125 2 2 3 3 Women > 125 3 3 4 4 Men < 200 3 3 4 4 Men > 200 4 4 5 5 - In one embodiment, the present invention also provides for a method of making a nutritional composition that includes the steps of mixing the following ingredients: L-arginine HCL, L-arginine alphaketoglutarate, creatine, L-aspartic acid, L-citrulline, ginseng root extract and maritime pine (bark) extract; and in an additional step, adding the following excipients: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, dicalcium phosphate, polyvinyl alcohol, polyethylene glycol, FD&C Red No. 40, talc, and titanium dioxide. The method also includes the step of blending and mixing for 30 minutes. Finally, the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- In addition, the present invention provides for a method of making a nutritional composition including the steps of mixing the following ingredients: L-arginine HCL, L-arginine alphaketoglutarate, creatine, L-leucine and L-valine; and in an additional step, adding the following excipient: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, dicalcium phosphate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, and talc. The method also includes the step of blending and mixing for 30 minutes. Finally, the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- In addition, the present invention provides for a method of making a nutritional composition including the steps of mixing the following ingredients: L-arginine HCL and L-arginine alpha ketoglutarate, creatine, L-leucine and L-valine; and in an additional step, adding the following excipient: potassium chloride, cellulose, dextrose, stearic acid, silica, magnesium stearate, ethyl cellulose, FD&C Red No. 40, polyvinyl alcohol, polyethylene glycol, talc, and dicalcium phosphate which had been pre-sifted. The method also includes the step of blending and mixing for 30 minutes. Finally, the method includes the steps of checking for uniformity/homogeneity and then aliquoting into a serving.
- According to various embodiments, the present invention may also provide for a timed release delivery system for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, which includes a combination of pharmaceutical grade excipients including Hydroxypropyl Methyl Cellulose (Methocel K100M Premium CR EP-Hypromellose 2208 USP XXII), Ethyl Cellulose (Ethocel Standard FP Premium—NF XVII), and Hydroxypropylcellulose (Klucel LF—NF XVII).
- The present invention, according to one embodiment thereof, may also provide for a timed release delivery system for a novel nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, which comprises a hydrophilic caplet matrix system comprising water-soluble (i.e., Hydroxypropyl Methyl Cellulose and Hydroxypropylcellulose) and water-insoluble (i.e., Ethyl Cellulose) polymers uniformly incorporated at a specified ratio.
- In one timed release delivery system of the present invention, the novel nutritional composition includes a hydrophilic caplet matrix system which is in the ratio of 1 Hydroxypropylcellulose:1 Ethyl Cellulose:0.5 Hydroxypropyl Methyl Cellulose.
- Although the following examples illustrate the practice of the present invention in some of its embodiments, the examples should not be construed as limiting the scope of the invention. Other embodiments will be apparent to one skilled in the art from consideration of the specification and examples.
- A serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
4.852 Ingredients G/serving Formula % L-arginine HCL 3.000 40.000% Ginseng (25% ginsenosides) 0.050 0.667% Creatine Malate 1.500 20.000% L-arginine alpha ketaglutarate 0.100 1.333% Citrulline 0.100 1.333% L-aspartic acid 0.100 1.333% Pycnogenol 0.002 0.027% Other Ingredients: 2.648 35.307% G/serving Potassium Chloride 0.250 3.333% Cellulose 0.883 11.773% Dextrose 0.057 0.760% Stearic Acid 0.560 7.467% Silica 0.070 0.933% Magnesium Stearate 0.035 0.467% Ethyl Cellulose 0.455 6.067% Dicalcium Phosphate 0.338 4.507% Total 7.500 100.000% - Optionally, the caplet form may contain a coating such as Opadry II.
- A serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in accordance with the following directions and dosing chart:
- DIRECTIONS: Reference is made to the chart below. Based upon a person's bodyweight, one serving (4 to 5 caplets) is taken with an 8 oz. glass of water, 2 times daily. On days of a person's workout, one of these servings is taken, 30 to 60 minutes before the workout. Ten caplets in a 24-hour period should not be exceeded. Ten 8 oz. glasses of water should be ingested daily for general good health. The product may be taken by men.
CHART Up to 200 lbs Over 200 lbs 8 caplets daily 10 caplets daily Take 4 caplets 30 minutes before Take 5 caplets 30 minutes before breakfast and again 30 minutes breakfast and aqain 30 minutes before before lunch. lunch. - An alternate embodiment of the serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
4.700 Ingredients g/serving Formula % L-arginine HCL 2.900 38.667% Creatine Monohydrate 1.500 20.000% L-arginine alpha ketaglutarate 0.100 1.333% L-Leucine 0.100 1.333% L-Valine 0.100 1.333% Other Ingredients: 2.800 37.333% g/serving Potassium Chloride 0.250 3.333% Cellulose 1.035 13.800% Dextrose 0.057 0.760% Stearic Acid 0.560 7.467% Silica 0.070 0.933% Magnesium Stearate 0.035 0.467% Ethyl Cellulose 0.455 6.067% Dicalcium Phosphate 0.338 4.507% Total 7.500 100.000% Coating: Opadry II Grey - Optionally, the caplet form may contain a coating such as Opadry II.
- An alternate embodiment of the serving of the nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in accordance with the following directions and dosing chart:
DIRECTIONS FOR MEN AND WOMEN: Based upon a person's gender and bodyweight, take one serving (2 to 5 caplets) with an 8 oz. glass of water, 2 times daily. On days of workout, take 1 of these servings, 30 to 60 minutes before workout. Do not exceed 10 caplets in a 24-hour period. Consume ten 8 fl. oz. glasses of water daily for general good health. Read the entire label before use and follow directions. Minimum Maximum daily serving daily serving (caplets) Second (caplets) Second Gender/lbs First serving Serving First serving Serving Women < 125 2 2 3 3 Women > 125 3 3 4 4 Men < 200 3 3 4 4 Men > 200 4 4 5 5 - A timed release delivery system for a serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual including a hydrophilic caplet matrix of Hydroxypropyl Methyl Cellulose (Methocel K100M Premium CR EP-Hypromellose 2208 USP XXII), Ethyl Cellulose (Ethocel Standard FP Premium—NF XVII), and Hydroxypropylcellulose (Klucel LF—NF XVII). The average (n=6) % of labeled amount of arginine dissolved from one caplet of the nutritional supplement for inducing muscle pump and enhancing muscle stimulus and recovery in 900 ml of 0.1N Hydrochloric Acid:
Average % of Labeled Amount of Arginine Average Mg of Arginine Time (Minutes) Dissolved ± Std. Dev. Dissolved ± Std. Dev. 15 10.69 ± 1.69 53.02 ± 8.41 30 21.18 ± 3.82 105.02 ± 18.92 45 26.58 ± 9.62 131.63 ± 47.6 60 32.74 ± 5.62 161.9 ± 27.76 120 57.66 ± 6.99 284.61 ± 34.49 240 91.65 ± 13.76 451.18 ± 67.49 360 113.30 ± 32.21 555.59 ± 157.52 480 120.94 ± 38.41 590.13 ± 185.8 - A serving of the nutritional supplement for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response e.g., blood flow and circulation, in an individual, includes the following ingredients in caplet form.
Serving: 4.500 Ingredient #: g/serving 3 Caplets Ingredients 1 L-arginine HCL 1.740 38.6667% 2 Creatine Monohydrate 0.900 20.0000% 3 L-arginine alpha 0.060 1.3333% ketoglutarate 4 L-leucine 0.060 1.3333% 5 L-valine 0.060 1.3333% Other Ingredients: 6 Potassium Chloride 0.150 3.3333% 7 Cellulose 0.621 13.8000% 8 Dextrose 0.034 0.7600% 9 Stearic Acid 0.336 7.4667% 10 Silica 0.042 0.9333% 11 Magnesium Stearate 0.021 0.4667% 12 Ethyl Cellulose 0.273 6.0667% 13 Dicalcium Phosphate 0.203 4.5067% Coating: Opadry II Red 4.500 100.000% - A serving of the nutritional supplement (PUMP-TECH GRAPE FLAVOR) for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, in an individual, includes the following ingredients in powder form reconstituted into a drink.
Dietary Ingredient per serving Actives/ Dietary Ingredient Name Actives % (g) serving (g) Formula % L-arginine 4.0000 68.3527% Di-Creatine Malate 1.5000 25.6323% Creatine 63 0.9450 L-arginine alpha ketaglutarate (2:1) 0.1000 1.7088% Arginine 69 0.0690 Picamilone HCL 0.1000 1.7088% Asian Ginseng Powder root extract 0.0500 0.8544% (Panax ginseng) Ginsenosides (standardized) 25 0.0125 L-Citrulline 0.0500 0.8544% L-aspartic acid 0.0500 0.8544% French Maritime Pine Bark Extract 0.0020 0.0342% Proanthocyanidins Standardized (Pinus 70 0.0014 Maritima) 5.8520 100.00% Other Ingredients g/serving % Dextrose 6.0000 62.9% Citric Acid 2.4600 25.8% SD N&A Bitter Blocker 0.6250 6.5% SD N&A Concord Grape Flavor 0.1870 2.0% Natural Sweetness Modifier Flavor 0.1750 1.8% Sucralose 0.0550 0.6% Acesulfame K 0.0270 0.3% FD&C Blue #1 (10%) 0.0080 0.1% FD&C Red #40 0.0060 0.1% 9.5430 100.00% - One serving of the supplement of Example 7 is consumed by a human, twice daily.
- A serving of the nutritional composition (PUMPTECH FRUIT PUNCH FLAVOR) for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in powder form reconstituted into a drink.
Dietary Ingredient Dietary Ingredient per serving Actives/ Name Actives % (g) serving (g) Formula % L-arginine 4.0000 68.3527% Di-Creatine Malate 1.5000 25.6323% Creatine 63 0.9450 L-arginine alpha 0.1000 1.7088% ketaglutarate (2:1) Arginine 69 0.0690 Picamilone HCL 0.1000 1.7088% Asian Ginseng 0.0500 0.8544% Powder root extract (Panax ginseng) Ginsenosides 25 0.0125 Standardized L-Citrulline 0.0500 0.8544% L-aspartic acid 0.0500 0.8544% French Maritime 0.0020 0.0342% Pine Bark Extract Proanthocyanidins 70 0.0014 Standardized (Pinus Maritima) 5.8520 100.00% Other Ingredients g/serving % Dextrose 6.0000 59.9% Citric Acid 2.4600 24.5% SD N&A Bitter Blocker 0.6250 6.2% SD Natural Pineapple Flavor WONF 0.3700 3.7% SD N&A Fruit Punch Flavor 0.3000 3.0% Natural Sweetness Modifier Flavor 0.1750 1.7% Sucralose 0.0550 0.5% Acesulfame K 0.0270 0.3% FD&C Red #40 0.0090 0.1% 10.0210 100.00% - One serving of the supplement of Example 9 is consumed by a human, twice daily.
- A serving of the nutritional composition (PUMPTECH CAPLET) for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, e.g., blood flow and circulation, is preferably consumed in caplet form.
Dietary Ingredient Dietary Ingredient per serving Actives/ Name Actives % (g) serving (g) Formula % L-arginine 4.0000 68.3527% Di-Creatine Malate 1.5000 25.6323% Creatine 63 0.9450 L-arginine alpha 0.1000 1.7088% ketaglutarate (2:1) Arginine 66 0.0660 Picamilon HCL 0.1000 1.7088% Asian Ginseng 0.0500 0.8544% Extract (Panax Ginseng) Std to Ginsenosides 25 0.0125 L-Citrulline 0.0500 0.8544% L-aspartic acid 0.0500 0.8544% French Maritime 0.0020 0.0342% Pine Bark Extract (Pinus maritima) Std to 70 0.0014 Proanthocyanidins 5.8520 100.00% Other Ingredients g/serving % Potassium Chloride 0.0000 Cellulose 0.0000 Dextrose 0.0000 Stearic Acid 0.0000 Silica 0.0000 Magnesium Stearate 0.0000 Ethyl Cellulose 0.0000 Dicalcium Phosphate 0.0000 Coating: Opadry II Red 0.0000 Polyvinyl Alcohol 0.0000 Polyethylene Glycol 0.0000 FD & C Red #40 AC Aluminum Lake 0.0000 Talc 0.0000 Titanium Dioxide 0.0000 0.0000 0.0000% - One serving of the supplement of Example 11 is consumed by a human, twice daily, each serving including 5 caplets.
Claims (21)
1. A nutritional composition for at least one of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response, in individuals, the nutritional composition comprising L-arginine and creatine.
2. The nutritional composition of claim 1 , further comprising L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract.
3. The nutritional composition of claim 1 , wherein the L-arginine includes L-arginine HCL and L-arginine alphaketoglutarate.
4. The nutritional composition of claim 2 , wherein the L-arginine includes L-arginine base and L-arginine alphaketoglutarate.
5. The nutritional composition of claim 1 , wherein the creatine includes di-creatine malate.
6. The nutritional composition of claim 1 , further comprising L-leucine and L-valine.
7. The nutritional composition of claim 1 , wherein the nutritional composition is provided in the form of one of a caplet and a powder suitable for reconstitution in a liquid.
8. A method for at least one of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in individuals, the method comprising the step of:
consuming a nutritional composition comprising L-arginine and creatine.
9. The method of claim 8 , wherein the nutritional composition further comprises L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract.
10. The method of claim 9 , wherein the L-arginine includes L-arginine HCL and L-arginine alphaketoglutarate.
11. The method of claim 8 , wherein the L-arginine includes L-arginine base and L-arginine alphaketoglutarate.
12. The method of claim 8 , wherein the creatine includes di-creatine malate.
13. The method of claim 8 , wherein the nutritional composition further comprises L-leucine and L-valine.
14. The method of claim 8 , wherein the nutritional composition is consumed in the form of one of a caplet and a powder suitable for reconstitution in a liquid.
15. A method of manufacturing a nutritional composition for at least one of enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in individuals, the method comprising the steps of:
creating a mixture of L-arginine and creatine;
blending the mixture; and
aliquoting the mixture into a serving.
16. The method of claim 15 , wherein the mixture is aliquoted into a serving, the serving in the form of one of a caplet and a powder beverage mix.
17. The method of claim 15 , further comprising the step of adding in the mixture at least one of L-citrulline, L-aspartic acid, ginseng root extract, and maritime pine (bark) extract.
18. The method of claim 15 , further comprising the step of adding in the mixture at least one of L-leucine and L-valine.
19. The method of claim 15 , wherein the step of adding in the mixture the L-arginine includes adding L-arginine HCL and L-arginine alphaketoglutarate.
20. The method of claim 15 , wherein the step of adding in the mixture the L-arginine includes adding L-arginine base and L-arginine alphaketoglutarate.
21. The method of claim 15 , wherein the step of adding in the mixture the creatine includes adding di-creatine malate.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/119,168 US20050256192A1 (en) | 2004-04-30 | 2005-04-29 | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual |
| US11/876,390 US20080089962A1 (en) | 2004-09-24 | 2007-10-22 | Nutritional composition for facilitating muscle pumps |
| US12/291,478 US7939113B2 (en) | 2004-04-30 | 2008-11-10 | Nutritional composition for facilitating muscle pumps |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56712704P | 2004-04-30 | 2004-04-30 | |
| US61344104P | 2004-09-24 | 2004-09-24 | |
| US65878205P | 2005-03-03 | 2005-03-03 | |
| US11/119,168 US20050256192A1 (en) | 2004-04-30 | 2005-04-29 | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/876,390 Continuation-In-Part US20080089962A1 (en) | 2004-04-30 | 2007-10-22 | Nutritional composition for facilitating muscle pumps |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20050256192A1 true US20050256192A1 (en) | 2005-11-17 |
Family
ID=35320722
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/119,168 Abandoned US20050256192A1 (en) | 2004-04-30 | 2005-04-29 | Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual |
| US12/291,478 Expired - Fee Related US7939113B2 (en) | 2004-04-30 | 2008-11-10 | Nutritional composition for facilitating muscle pumps |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/291,478 Expired - Fee Related US7939113B2 (en) | 2004-04-30 | 2008-11-10 | Nutritional composition for facilitating muscle pumps |
Country Status (3)
| Country | Link |
|---|---|
| US (2) | US20050256192A1 (en) |
| CA (1) | CA2564886A1 (en) |
| WO (1) | WO2005107735A2 (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070014878A1 (en) * | 2005-03-18 | 2007-01-18 | Gardiner Paul T | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| WO2007002294A3 (en) * | 2005-06-22 | 2007-03-29 | Advocare International L P | Composition for enhancing cellular energy |
| US20070141122A1 (en) * | 2005-12-21 | 2007-06-21 | Angel Sports Nutrition, Inc. | Nutritional composition and method of manufacture |
| WO2008105325A1 (en) * | 2007-02-23 | 2008-09-04 | Kyowa Hakko Bio Co., Ltd. | Citrulline-containing beverage |
| US20090105196A1 (en) * | 2007-06-22 | 2009-04-23 | Belinda Tsao Nivaggioli | Use of creatine compounds to treat dermatitis |
| EP2007407A4 (en) * | 2006-03-20 | 2009-08-19 | Ripped Formulations Ltd | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| US20110044965A1 (en) * | 2008-04-02 | 2011-02-24 | Androsystems S.R.L. | L-citrulline for treating endothelial dysfunction and erectile dysfunction |
| US20110123654A1 (en) * | 2008-06-06 | 2011-05-26 | Ralf Jaeger | Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| US20110217393A1 (en) * | 2010-02-23 | 2011-09-08 | Grise Michel | Anti-fatigue composition |
| US20120045426A1 (en) * | 2010-08-21 | 2012-02-23 | St Cyr John A | Compositions for reducing the deleterious effects of stress and aging |
| WO2016123659A1 (en) * | 2015-02-05 | 2016-08-11 | Plasmaide Pty Ltd | A composition and formulation of pine bark extract (pbe) for providing health benefits |
| US11534419B2 (en) | 2011-04-13 | 2022-12-27 | Thermolife International, Llc | N-acetyl beta alanine methods of use |
| US11723917B2 (en) | 2007-02-26 | 2023-08-15 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
| US11759477B2 (en) | 2007-02-26 | 2023-09-19 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
| US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
| US12156886B2 (en) | 2020-11-12 | 2024-12-03 | Thermolife International, Llc | Methods of increasing blood oxygen saturation |
| US12227483B1 (en) | 2007-09-18 | 2025-02-18 | Thermolife International, Llc | Amino acid compositions |
| US12441615B2 (en) | 2021-02-11 | 2025-10-14 | Thermolife International, Llc | Method of administering nitric oxide gas |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007009450A (en) * | 2005-02-07 | 2007-10-23 | New Cell Formulations Ltd | Creatine hydroxycitric acids salts and methods for their production and use in individuals. |
| EP2679223A1 (en) * | 2006-04-04 | 2014-01-01 | Nestec S.A. | Treatments using citrulline |
| ES2861583T3 (en) * | 2007-10-10 | 2021-10-06 | Kyowa Hakko Bio Co Ltd | Rapid-acting oral preparation that can increase the level of arginine in the blood and comprises citrulline and arginine |
| CN102028230B (en) * | 2010-12-08 | 2014-12-10 | 江南大学 | Health care product auxiliary material and application thereof |
| MX2013012228A (en) * | 2011-04-18 | 2013-12-06 | Nestec Sa | Nutritional compositions comprising alpha-hydroxyisocaproic acid. |
| CN103263018A (en) * | 2013-04-27 | 2013-08-28 | 北京中国科学院老专家技术中心 | Nitric oxide functional beverage and preparation method thereof |
| US11102994B2 (en) * | 2014-08-21 | 2021-08-31 | Clearfast Inc. | Pre-operative carbohydrate-rich beverage composition and methods of treatment |
| US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
| WO2017075289A1 (en) | 2015-10-27 | 2017-05-04 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698360A (en) * | 1985-04-09 | 1987-10-06 | Societe Civile D'investigations Pharmacologiques D'aquitaine | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
| US5783603A (en) * | 1995-05-15 | 1998-07-21 | Sabinsa Corporation | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss |
| US6160172A (en) * | 1997-08-27 | 2000-12-12 | Vittal Mallya Scientific Research Foundation | Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties |
| US6203820B1 (en) * | 1998-05-28 | 2001-03-20 | Brice E. Vickery | Compositions and methods for enhancing protein anabolism and detoxification |
| US6383482B1 (en) * | 2000-08-24 | 2002-05-07 | Vitacost.Com, Inc. | Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus |
| US6384087B1 (en) * | 2000-09-01 | 2002-05-07 | University Of Tennesseee Research Corporation, Inc. | Materials and methods for the treatment or prevention of obesity |
| US6638542B2 (en) * | 2001-09-20 | 2003-10-28 | Nutricia N.V. | Reducing appetite in mammals by administering procyanidin and hydroxycitric acid |
| US20030207942A1 (en) * | 2002-04-30 | 2003-11-06 | Unibar Corporation | Hydroxycitric acid salt composition and method of making |
| US20040071825A1 (en) * | 2002-10-15 | 2004-04-15 | Christopher Lockwood | Agglomerated granular protein-rich nutritional supplement |
| US20040229953A1 (en) * | 2003-05-12 | 2004-11-18 | Gokaraju Ganga Raju | Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3736776B2 (en) | 1997-03-25 | 2006-01-18 | 宝ホールディングス株式会社 | New calcium composition |
| JP2001527022A (en) | 1997-07-14 | 2001-12-25 | ラジュ、ジー・ガンガ | Hydroxycitric acid compositions, supplements and supplements and foods made therefrom and methods of using them in reducing body weight |
| US20020068365A1 (en) * | 1998-07-28 | 2002-06-06 | Eric H. Kuhrts | Controlled release nitric oxide producing agents |
| US6541026B2 (en) | 1999-12-16 | 2003-04-01 | Harry J. Siskind | Nutritional composition, methods of producing said composition and methods of using said composition |
| AU2001282373A1 (en) * | 2000-05-26 | 2001-12-03 | Horphag Research Limited | Use of proanthocyanidins as an active ingredient of a stimulator and l-arginine or its salts as a source of nitric oxide to relieve symptoms of erectile dysfuntion |
| US20030119913A1 (en) | 2001-12-20 | 2003-06-26 | Ohia Sunny E. | Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| WO2003088947A1 (en) * | 2002-04-22 | 2003-10-30 | Experimental & Applied Sciences, Inc. | Food supplements containing 4-hydroxyisoleucine and creatine |
-
2005
- 2005-04-29 US US11/119,168 patent/US20050256192A1/en not_active Abandoned
- 2005-04-29 CA CA002564886A patent/CA2564886A1/en not_active Abandoned
- 2005-04-29 WO PCT/US2005/014984 patent/WO2005107735A2/en not_active Ceased
-
2008
- 2008-11-10 US US12/291,478 patent/US7939113B2/en not_active Expired - Fee Related
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4698360A (en) * | 1985-04-09 | 1987-10-06 | Societe Civile D'investigations Pharmacologiques D'aquitaine | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
| US4698360B1 (en) * | 1985-04-09 | 1997-11-04 | D Investigations Pharmacologiq | Plant extract with a proanthocyanidins content as therapeutic agent having radical scavenger effect and use thereof |
| US5783603A (en) * | 1995-05-15 | 1998-07-21 | Sabinsa Corporation | Potassium hydroxycitrate for the suppression of appetite and induction of weight loss |
| US6160172A (en) * | 1997-08-27 | 2000-12-12 | Vittal Mallya Scientific Research Foundation | Soluble double metal salt of group IA and IIA of (-) hydroxycitric acid, process of preparing the same and its use in beverages and other food products without effecting their flavor and properties |
| US6203820B1 (en) * | 1998-05-28 | 2001-03-20 | Brice E. Vickery | Compositions and methods for enhancing protein anabolism and detoxification |
| US6383482B1 (en) * | 2000-08-24 | 2002-05-07 | Vitacost.Com, Inc. | Weight loss composition containing green tea, hydroxycitric acid, 5-hydroxytryptophan, glucomannan, picolinate and lactobacillus |
| US6384087B1 (en) * | 2000-09-01 | 2002-05-07 | University Of Tennesseee Research Corporation, Inc. | Materials and methods for the treatment or prevention of obesity |
| US6638542B2 (en) * | 2001-09-20 | 2003-10-28 | Nutricia N.V. | Reducing appetite in mammals by administering procyanidin and hydroxycitric acid |
| US20030207942A1 (en) * | 2002-04-30 | 2003-11-06 | Unibar Corporation | Hydroxycitric acid salt composition and method of making |
| US20040071825A1 (en) * | 2002-10-15 | 2004-04-15 | Christopher Lockwood | Agglomerated granular protein-rich nutritional supplement |
| US20040229953A1 (en) * | 2003-05-12 | 2004-11-18 | Gokaraju Ganga Raju | Process for preparing highly water soluble double salts of hydroxycitric acid particularly alkali and alkaline earth metal double salts |
Cited By (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070014878A1 (en) * | 2005-03-18 | 2007-01-18 | Gardiner Paul T | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| US7943183B2 (en) | 2005-03-18 | 2011-05-17 | Gardiner Paul T | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| WO2007002294A3 (en) * | 2005-06-22 | 2007-03-29 | Advocare International L P | Composition for enhancing cellular energy |
| US20070141122A1 (en) * | 2005-12-21 | 2007-06-21 | Angel Sports Nutrition, Inc. | Nutritional composition and method of manufacture |
| EP2007407A4 (en) * | 2006-03-20 | 2009-08-19 | Ripped Formulations Ltd | Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| WO2008105325A1 (en) * | 2007-02-23 | 2008-09-04 | Kyowa Hakko Bio Co., Ltd. | Citrulline-containing beverage |
| US11759477B2 (en) | 2007-02-26 | 2023-09-19 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
| US11723917B2 (en) | 2007-02-26 | 2023-08-15 | Heartbeet Ltd. | Compositions of nitrates and methods of use thereof |
| US20090105196A1 (en) * | 2007-06-22 | 2009-04-23 | Belinda Tsao Nivaggioli | Use of creatine compounds to treat dermatitis |
| US12473261B2 (en) | 2007-09-18 | 2025-11-18 | Thermolife International, Llc | Amino acid compositions |
| US12448357B1 (en) | 2007-09-18 | 2025-10-21 | Thermolife International, Llc | Amino acid compositions |
| US12240819B1 (en) | 2007-09-18 | 2025-03-04 | Thermolife International, Llc | Amino acid compositions |
| US12227483B1 (en) | 2007-09-18 | 2025-02-18 | Thermolife International, Llc | Amino acid compositions |
| US8802162B2 (en) | 2008-04-02 | 2014-08-12 | Androsystems S.R.L. | L-citrulline for treating endothelial dysfunction and erectile dysfunction |
| US20110044965A1 (en) * | 2008-04-02 | 2011-02-24 | Androsystems S.R.L. | L-citrulline for treating endothelial dysfunction and erectile dysfunction |
| US20110123654A1 (en) * | 2008-06-06 | 2011-05-26 | Ralf Jaeger | Synergistic enhancement of cellular ergogenic nutrient uptake, like creatine or carnitine, with tarragon |
| US20110217393A1 (en) * | 2010-02-23 | 2011-09-08 | Grise Michel | Anti-fatigue composition |
| US9408894B2 (en) | 2010-02-23 | 2016-08-09 | Michel Grise | Anti-fatigue composition |
| US20160199460A1 (en) * | 2010-08-21 | 2016-07-14 | Hydropep, Llc | Compositions for reducing the deleterious effects of stress and aging |
| US20120045426A1 (en) * | 2010-08-21 | 2012-02-23 | St Cyr John A | Compositions for reducing the deleterious effects of stress and aging |
| US11534419B2 (en) | 2011-04-13 | 2022-12-27 | Thermolife International, Llc | N-acetyl beta alanine methods of use |
| WO2016123659A1 (en) * | 2015-02-05 | 2016-08-11 | Plasmaide Pty Ltd | A composition and formulation of pine bark extract (pbe) for providing health benefits |
| US12156886B2 (en) | 2020-11-12 | 2024-12-03 | Thermolife International, Llc | Methods of increasing blood oxygen saturation |
| US11865139B2 (en) | 2020-11-12 | 2024-01-09 | Thermolife International, Llc | Method of treating migraines and headaches |
| US12441615B2 (en) | 2021-02-11 | 2025-10-14 | Thermolife International, Llc | Method of administering nitric oxide gas |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005107735A2 (en) | 2005-11-17 |
| US20090155379A1 (en) | 2009-06-18 |
| CA2564886A1 (en) | 2005-11-17 |
| WO2005107735A3 (en) | 2006-07-13 |
| US7939113B2 (en) | 2011-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7939113B2 (en) | Nutritional composition for facilitating muscle pumps | |
| EP2210600B1 (en) | Rapid-acting, blood-arginine-level-increasable oral preparation comprising citrulline and arginine | |
| US20060083793A1 (en) | Nutritional composition for promoting muscle performance and acting as hydrogen (H+) blocker | |
| US20110064712A1 (en) | Dietary Supplement Compositions and Methods of Making and Using the Same | |
| JP2873497B2 (en) | Lipid metabolism regulator | |
| US20200237792A1 (en) | Palatinose for enhancing dietary supplement and pharmaceutical delivery | |
| US20090297640A1 (en) | Nutritional composition for increasing creatine uptake in skeletal muscle | |
| JP2011509293A (en) | Compositions and methods for increasing muscle mass, strength and functional ability of the elderly | |
| US20090306209A1 (en) | Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same | |
| US20230089723A1 (en) | Amino acid compositions and methods for muscle and myotube modulation | |
| US5626831A (en) | Method for relief and prevention of common cold, and compositions | |
| US20080089962A1 (en) | Nutritional composition for facilitating muscle pumps | |
| US20150224136A1 (en) | Performance-Enhancing Nasal Irrigation | |
| WO1995022967A1 (en) | Analgesic activity enhancer | |
| Kobrin et al. | Antihypertensive duration of action of cilazapril in patients with mild to moderate essential hypertension | |
| EP3809882A1 (en) | Nutritional compositions for enhancement of muscle performance | |
| JP2006510640A (en) | Formulations that can be administered to the gastrointestinal tract and uses thereof | |
| TWI377937B (en) | Non-essential amino acids containing pharmaceutical composition and uses thereof | |
| JP2019142781A (en) | Drunkenness countermeasure composition | |
| JP2018121535A (en) | Beverage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: PUMP FORMULATIONS LTD., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GARDINER, PAUL T.;HEUER, MARVIN A.;REEL/FRAME:016550/0077;SIGNING DATES FROM 20050719 TO 20050720 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |